Latest News

New COVID shots will be available in September


 

The newest version of the COVID-19 vaccine will be available by the end of September, according to the Centers for Disease Control and Prevention.

The updated vaccine still needs final sign-offs from the Food and Drug Administration and the CDC.

“We anticipate that they are going to be available for most folks by the third or fourth week of September,” Director Mandy Cohen, MD, MPH, said on a podcast hosted by former White House COVID adviser Andy Slavitt. “We are likely to see this as a recommendation as an annual COVID shot, just as we have an annual flu shot. I think that will give folks more clarity on whether they should get one or not.”

For people who are considering now whether they should get the currently available COVID vaccine or wait until the new one comes out, Dr. Cohen said that depends on a person’s individual risk. People who are 65 or older or who have multiple health conditions should go ahead and get the currently available shot if it’s been more than 6-8 months since their last dose. For all other people, it’s OK to wait for the new version.

Analysts expect low demand for the updated vaccine. About 240 million people in the United States got at least one dose when vaccines first became available in 2021, Reuters reported, but that number dropped to less than 50 million getting the most updated shot in the fall of 2022.

“Take a look at what happened last winter. It was 50 million in the U.S., and it seems likely to be lower than that, given that there’s less concern about COVID this year than last year,” Michael Yee, a health care industry analyst for the firm Jefferies, told Reuters.

Dr. Cohen noted during the podcast that the recent uptick in virus activity should be taken in context.

“What we’re seeing right now in August of 2023 are small increases of folks getting COVID. We are still at some of the lowest hospitalizations that we’ve been at in the past 3 years,” she said. “Even a 10% increase on a very, very small number is still very small. My level of concern continues to be low.”

A version of this article was first published on WebMD.com .

Recommended Reading

Latest data: COVID vaccine safety, protection, and breakthrough infections in inflammatory, autoimmune diseases
MDedge Infectious Disease
FDA panel backs new COVID booster focusing only on variants
MDedge Infectious Disease
Postacute effects of COVID on par with those of sepsis, flu
MDedge Infectious Disease
Long COVID ‘brain fog’ confounds doctors, but new research offers hope
MDedge Infectious Disease
Nearly one in five in U.S. still hadn’t gotten COVID by end of 2022
MDedge Infectious Disease
Deer populations pose COVID risk to humans: Study
MDedge Infectious Disease
Long COVID and vaccines: Separating facts from falsehoods
MDedge Infectious Disease
New air monitor can detect COVID virus in 5 minutes
MDedge Infectious Disease
U.S. has new dominant COVID variant called EG.5
MDedge Infectious Disease
It may be time to pay attention to COVID again
MDedge Infectious Disease